Literature DB >> 903326

The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin.

W Farrell, M Wilks, F A Drasar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 903326     DOI： 10.1093/jac/3.5.459

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.

Authors:  G E Stein; D Gurwith; M Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

2.  Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.

Authors:  A M Bourgault; K R Forward; A R Ronald; G K Harding; M Thomson; G Grey
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

3.  Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Authors:  B P Goldstein; I F Ripamonti; G Bolzoni; G Carniti; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

4.  Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

5.  Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides.

Authors:  J G Allen; F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; L J Nisbet; P S Ringrose
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

Review 6.  Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.

Authors:  Charlotte M J Wesseling; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-08-10       Impact factor: 5.578

7.  Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Authors:  Javier Ariza; Mile Bosilkovski; Antonio Cascio; Juan D Colmenero; Michael J Corbel; Matthew E Falagas; Ziad A Memish; Mohammad Reza Hasanjani Roushan; Ethan Rubinstein; Nikolaos V Sipsas; Javier Solera; Edward J Young; Georgios Pappas
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.